Jeffrey Mosebrook's most recent trade in Integra Lifesciences Holdings Corp was a trade of 3,345 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.49 per share. | 03 Jul 2025 | 3,345 | 36,600 (0%) | 0% | 13.5 | 45,124 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.25 per share. | 01 Jul 2025 | 937 | 39,945 (0%) | 0% | 13.2 | 12,415 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 5,514 | 40,882 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 309 | 35,368 (0%) | 0% | 24.0 | 7,401 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 134 | 35,677 (0%) | 0% | 23.9 | 3,209 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 166 | 35,811 (0%) | 0% | 22.6 | 3,753 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 111 | 35,977 (0%) | 0% | 22.6 | 2,510 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Sale of securities on an exchange or to another person at price $ 21.58 per share. | 19 Aug 2024 | 1,191 | 36,088 (0%) | 0% | 21.6 | 25,701 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,356 | 37,279 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 3,410 | 27,270 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 223 | 27,047 (0%) | 0% | 35.9 | 8,001 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.22 per share. | 11 Mar 2024 | 130 | 23,860 (0%) | 0% | 36.2 | 4,709 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 124 | 26,923 (0%) | 0% | 35.9 | 4,449 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 10 Mar 2024 | 166 | 23,990 (0%) | 0% | 36.7 | 6,097 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 10 Mar 2024 | 110 | 24,156 (0%) | 0% | 36.7 | 4,040 | Common Stock |
| Integra Lifesciences Holdi... | A. Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 808 | 24,266 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & PAO | Sale of securities on an exchange or to another person at price $ 44.46 per share. | 09 Aug 2023 | 1,177 | 23,458 (0%) | 0% | 44.5 | 52,329 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 12,196 | 24,635 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 1,832 | 11,921 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 1,256 | 13,177 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 140 | 12,503 (0%) | 0% | 52.6 | 7,365 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 130 | 12,934 (0%) | 0% | 52.9 | 6,873 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 121 | 12,643 (0%) | 0% | 52.9 | 6,397 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 113 | 13,064 (0%) | 0% | 52.9 | 5,974 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 106 | 12,828 (0%) | 0% | 52.9 | 5,604 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.88 per share. | 10 Mar 2023 | 64 | 12,764 (0%) | 0% | 52.9 | 3,384 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 64 | 12,439 (0%) | 0% | 52.6 | 3,367 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 510 | 9,062 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 411 | 10,089 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 385 | 9,678 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin, PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 231 | 9,293 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Sale of securities on an exchange or to another person at price $ 56.22 per share. | 08 Dec 2022 | 279 | 8,552 (0%) | 0% | 56.2 | 15,684 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Sale of securities on an exchange or to another person at price $ 56.78 per share. | 02 Aug 2022 | 437 | 8,831 (0%) | 0% | 56.8 | 24,811 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 1,430 | 10,274 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 240 | 9,914 (0%) | 0% | 65.1 | 15,626 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 232 | 9,268 (0%) | 0% | 65.1 | 15,106 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 164 | 9,500 (0%) | 0% | 65.1 | 10,678 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 144 | 9,770 (0%) | 0% | 65.1 | 9,376 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 120 | 10,154 (0%) | 0% | 65.1 | 7,813 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 62 | 9,664 (0%) | 0% | 65.1 | 4,037 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 44 | 9,726 (0%) | 0% | 65.1 | 2,865 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,398 | 8,844 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 843 | 7,446 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 595 | 6,603 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Sale of securities on an exchange or to another person at price $ 70.88 per share. | 10 Nov 2021 | 700 | 6,008 (0%) | 0% | 70.9 | 49,616 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 1,327 | 6,913 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 102 | 6,749 (0%) | 0% | 68.1 | 6,946 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 62 | 6,851 (0%) | 0% | 68.1 | 4,222 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 41 | 6,708 (0%) | 0% | 68.1 | 2,792 | Common Stock |
| Integra Lifesciences Holdi... | Jeffrey A. Mosebrook | SVP, Fin & Princ Acct Officer | Sale of securities on an exchange or to another person at price $ 68.70 per share. | 02 Mar 2021 | 1,058 | 5,586 (0%) | 0% | 68.7 | 72,684 | Common Stock |